We are inching our way closer to the major catalysts. ASCO is coming this weekend but I do not think anything from ASCO is going to have the same impact on the sector as the adu decision or perhaps even the VRTX data. I am a little nervous in that ASCO usually has a sell […]
June 2nd Biotech Update
Well, at least we have a biotech deal. I will discuss it but I am not sure this is the deal the sector was hoping for and probably does not alter sentiment to a large degree. We still have a lot of catalysts coming and perhaps this deal is just the start of more to […]
June 1st Biotech Update
I was hoping that we would have a surge of M&A starting after this long weekend but I knew it was a pipedream and we are still waiting. There are still a ton of binary events coming in June (BIIB adu PDUFA, VRTX data, and ASCO to name a few) so we might not need […]
May 28th Biotech Update
We have had 3 green days in a row (assuming that today remains green). This is sadly the best the sector has done in awhile. If you look really hard you can see a mini uptrend with this being the first higher high after a higher low. I call it mini as it is still […]
May 27th Biotech Update
I think this is going to sound like a broken record given the lack of news but I do think we should have some more after (during) ASCO next week (and the adu PDUFA) but until then we likely have not much as we are likely entering the summer doldrums. In the summer news and […]
May 26th Biotech Update
I almost feel like we are stuck in a no news period until earnings but then I remember that we still have ASCO coming up (even though I am not sure it will provide very many fireworks for the sector). I have been talking about the sector being potentially in a trading zone but it […]
May 24th Biotech Update
What if I told you we are starting the week with slow news and no deal? Well, it is slow news but we do actually have a small deal (nothing that is nearly large enough to spark any rally but a deal nonetheless). In some ways, the fact that the sector seems to have stopped […]
May 20th Biotech Update
I sort of want to say that the sector is in no man’s land. We are not challenging key levels lower or higher and there does not seem to be a real bias one way or another. This is not necessarily a bad thing given where we have been and the struggles the sector has […]
May 19th Biotech Update
We do not have a ton of news but it has picked up a little this week, which is nice. It is also nice that the news has generally been positive (although not universally so). It is nice to see that the positive news is being treated as such (having positive effects on stock prices) […]
May 17th Biotech Update
Guess what no deals in the sector. We have a big deal outside of biotech but noting much going on in biotech. I still think this reverses at some point as these companies still need to boost their pipelines and bankers need deals to get their bonuses. Of course, it is possible that the dearth […]
May 14th Biotech Update
What a weird series of days. It is like the sector is an inverse ETf with the broader markets. I really thought we would be able to move with the broader market but I guess not. I think the relationship with the broader market is like just an odd quirk and what is really more […]
May 13th Biotech Update
The sector has been doing pretty well the past couple of days and that is in light of the broader market being pretty bad. That could be good sign and ideally we need to see that outperformance to continue on days in which the broader market is green. Today could be the day to test […]
May 12th Biotech Update
Good news and bad news. The sector broke its recent lows yesterday- bad news. It reversed and ended green- good news. I think the clear downtrend is not as clear but I also do not think we are in a good spot. The $120 level should be some decent support but it seems best case […]
May 10th Biotech Update
Not a great start to the week and not a lot of reasons to explain it. There is really no big news out this morning and perhaps that is part of the issue. With the narrative and sentiment already negative a day without anything positive is going to generally be weak. The big earnings have […]
May 7th Biotech (and MLP) Update
We broke to new lows so how far will we fall? That is the natural question but it actually looks like we hit what could be pretty strong support. So is it possible that we actually bounce as opposed to collapse? If you look at the previous lower lows, they are not actually that different. […]
May 6th Biotech Update
Well, yesterday starting really good with PFE finally getting some love and the sector on decent footing but it certainly did not end well. We are now at the recent lows with odds likely favoring breaking the lows and triggering another leg lower. In some ways this is fundamentally and sentiment driven. As I noted […]
Perimeter Medical Imaging AI Update – Thesis advancing to fruition
Perimeter Medical Imaging AI (PINK.v, PYNKF) is a Toronto-based company with U.S. headquarters in Dallas, Texas that is driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools. Giving physicians the ability to visualize microscopic tissue structures “real time” in the operating room has the potential to result in better long-term outcomes for patients […]
May 5th Biotech Update
I guess that is my bad for writing on a Tuesday when I usually do not write. The sector and market did not seem to like that at all, so my bad. In all seriousness, that was certainly not a good day but actually might be good. We now have a clear upside resistance level […]
May 4th Biotech Update
I usually do not have time to write on Tuesday but wanted to put out a quick note. In general, we are still in a decision area with the sector. We have broken the clear downtrend but are not out of the woods and have certainly not established a clear uptrend. In any case, I […]
May 3rd Biotech Update
Have we broken the downtrend? We are certainly in a much better position than before. We have not made a lower low and we are above what was the previous lower high. In other words, the clear downtrend is no longer that clear. We have not established a new uptrend but we are in the […]
